This bill creates a new joint legislative-executive committee on health care financing and sets out its membership, duties, procedures, and deadlines. Membership includes legislative members from the two largest caucuses in each chamber (the exact number wording is ambiguous), a governor appointee, the Health Care Authority director or designee, the secretaries or designees of DSHS and Health, the OFM director or designee, the Health Benefit Exchange CEO or designee, the insurance commissioner or designee, and a tribal representative knowledgeable in Indian health care delivery. This is a new statutory body and an advisory/investigatory procedural change, not a change creating a crime or penalty. The committee must meet first by August 1, 2026, elect a chair at that meeting, be staffed by the Office of Financial Management (which may contract for economic and actuarial analyses and facilitation), hold meetings open to the public under chapter 42.30 RCW with OFM publishing meeting information, and may reimburse members for travel as authorized under cited RCWs. It must consult professionals and stakeholders, coordinate with the Universal Health Care Commission, the Health Care Cost Transparency Board, and the Prescription Drug Affordability Board, investigate financing strategies and policy options for statewide health care access and affordable coverage, produce a preliminary report to the governor and legislature by January 1, 2027, a final report by November 1, 2027, and the committee expires January 1, 2028. The provided text leaves several gaps: the legislative membership wording is ambiguous, no funding or appropriation language for staffing or contracts is included, there are no procedures specified for selecting the tribal representative, and the text does not state any authority for implementing the committee’s recommendations. Only sections 1 and 2 are included here, so any additional provisions elsewhere in the bill are not available for review.

If enacted, the bill creates a short‑term joint legislative‑executive committee to study and develop policy options for funding statewide health care access and affordable coverage, with OFM officially staffing the group and authority to hire outside economic and actuarial help. The committee must meet publicly (first meeting by August 1, 2026), produce a preliminary report by January 1, 2027 and a final report by November 1, 2027, and then expire January 1, 2028; its work will draw on and coordinate with multiple state health boards and stakeholders and allow members to be reimbursed for travel. The most affected parties are the Office of Financial Management, which will take on staffing and contracting duties and likely absorb related workload and contracting costs; state agencies named for participation (Health Care Authority, DSHS, Department of Health, Health Benefit Exchange, Insurance Commissioner) and legislative members, who must provide time, data, and consultation; tribal representatives and health sector stakeholders, who will be asked to engage. The bill does not include funding or appropriation language, is unclear about exact legislative membership counts and how the tribal representative is chosen, and gives the committee only a planning role rather than authority to implement changes, so practical follow‑through and who pays for any recommended reforms remain uncertain.